Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM, NEW COLLABORATORS LIST

Open source

DOI
10.1016/j.rmed.2020.106220
Published
2021 Mar
Container
Respiratory medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmed.2020.106220,
  title = {Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.},
  author = {Ghofrani HA and Gomez Sanchez MA and Humbert M and Pittrow D and Simonneau G and Gall H and Grünig E and Klose H and Halank M and Langleben D and Snijder RJ and Escribano Subias P and Mielniczuk LM and Lange TJ and Vachiéry JL and Wirtz H and Helmersen DS and Tsangaris I and Barberá JA and Pepke-Zaba J and Boonstra A and Rosenkranz S and Ulrich S and Steringer-Mascherbauer R and Delcroix M and Jansa P and Šimková I and Giannakoulas G and Klotsche J and Williams E and Meier C and Hoeper MM and NEW COLLABORATORS LIST},
  year = {2021},
  journal = {Respiratory medicine},
  doi = {10.1016/j.rmed.2020.106220},
  url = {https://doi.org/10.1016/j.rmed.2020.106220}
}

RIS

TY  - JOUR
TI  - Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
AU  - Ghofrani HA
AU  - Gomez Sanchez MA
AU  - Humbert M
AU  - Pittrow D
AU  - Simonneau G
AU  - Gall H
AU  - Grünig E
AU  - Klose H
AU  - Halank M
AU  - Langleben D
AU  - Snijder RJ
AU  - Escribano Subias P
AU  - Mielniczuk LM
AU  - Lange TJ
AU  - Vachiéry JL
AU  - Wirtz H
AU  - Helmersen DS
AU  - Tsangaris I
AU  - Barberá JA
AU  - Pepke-Zaba J
AU  - Boonstra A
AU  - Rosenkranz S
AU  - Ulrich S
AU  - Steringer-Mascherbauer R
AU  - Delcroix M
AU  - Jansa P
AU  - Šimková I
AU  - Giannakoulas G
AU  - Klotsche J
AU  - Williams E
AU  - Meier C
AU  - Hoeper MM
AU  - NEW COLLABORATORS LIST
PY  - 2021
JO  - Respiratory medicine
DO  - 10.1016/j.rmed.2020.106220
UR  - https://doi.org/10.1016/j.rmed.2020.106220
ER  - 

APA

HA, G., MA, G. S., M, H., D, P., G, S., H, G., E, G., H, K., M, H., D, L., RJ, S., P, E. S., LM, M., TJ, L., JL, V., H, W., DS, H., I, T., JA, B., J, P., A, B., S, R., S, U., R, S., M, D., P, J., I, Š., G, G., J, K., E, W., C, M., MM, H., & LIST, N. C. (2021). Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.. Respiratory medicine. https://doi.org/10.1016/j.rmed.2020.106220

Source records